April is the best month for stocks historically, and there may be some tailwinds after March's strong gains. The S&P 500 has gained an average 1.7% in all Aprils going back to 1945.
In the week ahead, the market is in the lull ahead of the next earnings season. There is little on the economic calendar, but investor focus will be heavily on the Federal Reserve's minutes from its last meeting, expected Wednesday. That was the meeting where the central bank raised interest rates for the first time since 2018, and investors will be watching for any clues from the Fed about when it might start to unwind its balance sheet, another form of policy tightening.
Interest rates could consolidate in the coming week, after big moves in Treasury yields resulted in an inverted yield curve, a possible sign of recession. An inversion occurred Thursday when the yield on the 2-year note rose above that of the benchmark 10-year.
This weekend, CNBC Pro takes an in-depth look at opportunities for investors among obesity therapies. In the past, some treatments have proven to be either ineffective or too toxic. Now, new therapies can result in patients losing 15% or more of their body weight.
